Spark Therapeutics' Revolutionary Gene Therapy for Blindness Faces the FDA on Thursday Post author:Sam Post published:October 9, 2017 Post category:BioPharma October 10, 2017By Mark Terry… Source: BioSpace You Might Also Like Heptares Founder Shares Her Best Life Sciences Career Advice November 21, 2017 Regeneron Forges Out-of-the-Box R&D Pact With Boston's Decibel Therapeutics November 28, 2017 InDex Pharmaceuticals AB Appoints New CFO March 7, 2017
